Comparison of Erector Spina Plan Block and Trnsversus Abdominis Plan Block in Laparoscopic Nephrectomy: Prospective Randomized Clinical Trial

NCT ID: NCT05913167

Last Updated: 2024-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-15

Study Completion Date

2026-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nephrectomy pain was higher. erector spina plan block and transversus abdominis plan block had shown to be effective in abdominal surgeries. This study aimed to compare these two bloc analgesic efficacy in laparoscopic nephrectomy patients. The primary aim is postoperative morphine consumption.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients ASA 18-65 who will undergo laparoscopic nephrectomy are included in this prospective randomized clinical trial. Patients will be divided into two groups; erector spina and transversus abdominis plane block. Anesthesia will. induced with propofol, fentanyl, and rocuronium will be administered for muscle relaxation. Bispectral index monitoring will be used for monitorisation of the depth of anesthesia. Remifentanil was used during the whole procedure. the amount of consumption will be recorded. Patient-controlled device will be used with morphine. The postoperative morphine consumption will also be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Laparoscopic Nephrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

erector spina and transversus abdominis plane blocks
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Participants will not know which block was administered outcome assessors will not know which block was administered

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erector spina plan block

Erector spina plan block will be administered to the patients in this group.

Group Type ACTIVE_COMPARATOR

laparoscopic nephrectomy

Intervention Type PROCEDURE

laparoscopic nephrectomy

Transversus abdominis plan block

Transversus abdominis plan block will be administered to the patients in this group.

Group Type ACTIVE_COMPARATOR

laparoscopic nephrectomy

Intervention Type PROCEDURE

laparoscopic nephrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

laparoscopic nephrectomy

laparoscopic nephrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18-65 age
* patients undergoing laparoscopic nephrectomy
* ASA 1-3

Exclusion Criteria

* \<18- \>65 \< age
* patients undergoing open nephrectomy
* ASA 4-5
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kocaeli University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zehra Ipek ARSLAN

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kocaeli University

Kocaeli, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zehra Arslan

Role: CONTACT

0090303 ext. 8168

Zehra Arslan

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zehra Ipek ARSLAN, Associate Professor

Role: primary

00905325011339

Zehra I ARSLAN, Associate Professor

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LAPNEF2023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ESPB and ACB in Knee Arthroplasty
NCT05613101 COMPLETED NA